title: Minor amounts of plasma medium-chain fatty acids and no improved time trial performance after consuming lipids.
abstract: Medium-chain triacylglycerols (MCT) have a potential glycogen-saving effect during exercise due to rapid hydrolysis and oxidation. However, studies comparing intake of carbohydrates (CHO) plus 80-90 g MCT with intake of CHO alone have revealed different results. The present study tested performance after consumption of specific structured triacylglycerol, consisting of a mixture of medium-chain fatty acids and long-chain fatty acids, to prevent the adverse effects observed by MCT (pure medium-chain fatty acids) regarding gastrointestinal distress. Seven well-trained subjects cycled 3 h at 55% of maximum O2 uptake during which they ingested CHO or CHO plus specific structured triacylglycerols. Immediately after the constant-load cycling, the subjects performed a time trial of approximately 50-min duration. Breath and blood samples were obtained regularly during the experiment. Fatty acid composition of plasma triacylglycerols, fatty acids, and phospholipids was determined. Performance was similar after administration of CHO plus specific structured triacylglycerol [medium-, long-, and medium-chain fatty acid (MLM)] compared with CHO (50.0 +/- 1.8 and 50.8 +/- 3.6 min, respectively). No plasma 8:0 was detected in the plasma lipid classes, but the amount of phospholipid fatty acids was significantly higher after CHO+MLM compared with CHO intake. The lacking time trial improvement after intake of medium-chain fatty acids might be due to no available 8:0 in the systemic circulation. A higher level of plasma phospholipid fatty acids in the CHO+MLM compared with the CHO group was probably due to endogenous phospholipid release into chylomicrons.
authors.affiliation: BioCentrum-DTU, The Technical University of Denmark, Lyngby, Denmark. bvistisen@ifi.ku.dk
authors.forename: Bodil
authors.initials: B
authors.lastname: Vistisen
authors.forename: Lars
authors.initials: L
authors.lastname: Nybo
authors.forename: Xuebing
authors.initials: X
authors.lastname: Xu
authors.forename: Carl-Erik
authors.initials: CE
authors.lastname: Høy
authors.forename: Bente
authors.initials: B
authors.lastname: Kiens
mesh_terms: D000328:Adult; D015308:Anaerobic Threshold / Q000502:physiology; D001642:Bicycling / Q000502:physiology*; D001786:Blood Glucose / Q000378:metabolism; D004040:Dietary Carbohydrates / Q000494:pharmacology; D004041:Dietary Fats / Q000494:pharmacology*; D005080:Exercise Test; D005227:Fatty Acids / Q000097:blood*; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D010101:Oxygen Consumption / Q000187:drug effects / Q000502:physiology; D010743:Phospholipids / Q000097:blood; D011597:Psychomotor Performance / Q000187:drug effects*; D015203:Reproducibility of Results; D012964:Sodium / Q000097:blood; D014280:Triglycerides / Q000097:blood
chemical_list: D001786:Blood Glucose; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D005227:Fatty Acids; D006454:Hemoglobins; D008055:Lipids; D010743:Phospholipids; D014280:Triglycerides; D012964:Sodium